Effects of anakinra on clinical and radiological outcomes in rheumatoid arthritis

被引：0
|
作者：
Bresnihan, B [1 ]
机构：
[1] St Vincents Univ Hosp, Dublin 4, Ireland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2002年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Interleukin 1 (IL1) plays a central part in the pathophysiology of rheumatoid arthritis (RA).(1 2) The IL1 gene family includes IL1alpha, IL1beta, and IL1 receptor antagonist (IL1Ra). IL1alpha and IL1beta are both agonist molecules. There are two distinct IL1 receptors, designated type I (IL1RI) and type II (IL1RII). IL1 binding to IL1RI results in signal transduction and cell activation. IL1Ra is the third member of the IL1 gene family. The agonistic effects of IL1 arc partially blocked by the interaction between IL1Ra and IL1RI. When IL1Ra binds to IL1RI, it blocks the binding of IL1alpha and IL1beta and inhibits signal transduction. Recombinant human IL1Ra, anakinra, has been approved for the treatment of patients with rheumatoid arthritis (RA).
引用
收藏
页码：74 / 77
页数：4
相关论文
共 50 条
  • [41] RADIOLOGICAL ASSESSMENT OF RHEUMATOID ARTHRITIS
    KELLGREN, JH
    LAWRENCE, JS
    ANNALS OF THE RHEUMATIC DISEASES, 1957, 16 (04) : 485 - 493
  • [42] The radiological assessment of rheumatoid arthritis
    Scott, DL
    Laasonen, L
    Priolo, F
    Houssien, DA
    Bacarini, L
    Cerase, A
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1997, 15 (03) : S53 - S61
  • [43] Discordant Autoantibodies and Clinical Outcomes In Rheumatoid Arthritis
    Johnson, Dannette S.
    Erickson, Alan
    Cannon, Grant W.
    Kerr, Gail S.
    Caplan, Liron
    Reimold, Andreas M.
    Richards, John S.
    Schwab, Pascale
    Lazaro, Deana M.
    Khan, Nasim A.
    Cherascu, Bogdan
    Mikuls, Ted R.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S838 - S839
  • [44] METHOTREXATE TREATMENT OF RHEUMATOID-ARTHRITIS - EFFECTS ON RADIOLOGICAL PROGRESSION
    REYKDAL, S
    STEINSSON, K
    SIGURJONSSON, K
    BREKKAN, A
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1989, 18 (04) : 221 - 226
  • [45] Anakinra demonstrates a modest benefit for treating rheumatoid arthritis
    不详
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2009, 5 (02) : 123 - 123
  • [46] Tuberculous pyomyositis in a rheumatoid arthritis patient treated with anakinra
    Migkos, M. P.
    Somarakis, G. A.
    Markatseli, T. E.
    Matthaiou, M.
    Kosta, P.
    Voulgari, P. V.
    Drosos, A. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (05) : 734 - 736
  • [47] Erosion healing in rheumatoid arthritis after anakinra treatment
    Rau, R
    Sander, O
    Wassenberg, S
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (07) : 671 - 673
  • [48] Durability and rapidity of response to anakinra in patients with rheumatoid arthritis
    Schiff, MH
    DRUGS, 2004, 64 (22) : 2493 - 2501
  • [49] Safety of extended treatment with anakinra in patients with rheumatoid arthritis
    Fleischmann, R. M.
    Tesser, J.
    Schiff, M. H.
    Schechtman, J.
    Burmester, G-R
    Bennett, R.
    Modafferi, D.
    Zhou, L.
    Bell, D.
    Appleton, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (08) : 1006 - 1012
  • [50] Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
    Mahamid, Mahmud
    Mader, Reuven
    Safadi, Rifaat
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2011, 3 : 39 - 43
12345